The biologics license application for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma was accepted by the FDA with priority review.

Barcelona-based Sycai Medical has closed a €3M funding round backed by LUMO Labs, Ship2B Ventures, Athos Capital, and Namarel Ventures.

Researchers in Spain are working to develop faster, more accurate methods for detecting viruses like human norovirus and hepatitis A in fresh produce. The

Caffeine isn’t the only good thing about drinking coffee on the regular. "Coffee is also a unique source of soluble fiber ," Giulio Quarta, MD, a gastroenterologist at Gastroenterology Associates of New Jersey, tells Well+Good.

Edgecore Networks, a global leader in open infrastructure solutions, is thrilled to showcase its powerful Open Infrastructure solutions for AI, Telecom access and aggregation and the large enterprise at Mobile World Congress (MWC) 2025 in

Our Bureau, Bengaluru Monday, January 20, 2025, 14:30 Hrs [IST]

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Special Report' as President-elect Donald Trump is inaugurated as the 47th U.S. president, becoming the second to serve two non-consecutive terms.

Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from leukemia, lymphoma & multiple myeloma.

Immuneel, launched in 2019, initiated the trial on India’s first CAR T-cell therapy trial in 2022 for a novel autologous CD19-directed CAR-T cell therapy in patients with relapsed / refractory B cell malignancies. The trial was conducted across various hospitals including PGIMER in Chandigarh, and others in Bengaluru, and Chennai.

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the country’s first global CAR T-cell therapy, that uses genetically modified T cells to fight the terminal disease.

The opening two hours of the 2025 edition of the 24 Hours at Daytona ran caution free, with only a few retirements winnowing the 60+ car field.